Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.2K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

1.0K
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
1.0K
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

37.7K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.7K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

855
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
855
Liver Physiology01:30

Liver Physiology

4.2K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
4.2K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

249
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
249

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The metabolic vulnerability index predicts outcomes in patients with metabolic dysfunction associated steatotic liver disease.

Nature communications·2026
Same author

Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease with elevated aminotransferases: A multicenter, randomized, placebo-controlled trial.

Hepatology (Baltimore, Md.)·2026
Same author

Clinically distinct metabotypes of pediatric MASLD identified through unsupervised clustering of NASH CRN data.

Nature communications·2026
Same author

Longitudinal changes in cardiometabolic risk factors are associated with changes in liver stiffness in adults with MASLD.

Journal of hepatology·2026
Same author

Evaluation of Pathogenic Variants Associated With Monogenic Disorders of Dyslipidemia in Patients With Well Characterised MASLD.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Association between pattern of hepatic iron deposition and severity of MASH among patients enrolled in the NASH Clinical Research Network.

Hepatology communications·2025

Related Experiment Video

Updated: Mar 21, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.9K

Nonalcoholic fatty liver disease.

Elizabeth M Brunt1, Vincent W-S Wong2, Valerio Nobili3

  • 1Department of Pathology and Immunology, Washington University School of Medicine, 660 Euclid Avenue, Campus Box 8118, Saint Louis, Missouri 63110, USA.

Nature Reviews. Disease Primers
|May 19, 2016
PubMed
Summary

Nonalcoholic fatty liver disease (NAFLD) is a prevalent liver condition linked to obesity and insulin resistance. Current treatments focus on lifestyle changes, with new therapies targeting disease mechanisms under investigation.

More Related Videos

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

2.0K
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

7.9K

Related Experiment Videos

Last Updated: Mar 21, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.9K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

2.0K
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

7.9K

Area of Science:

  • Hepatology
  • Metabolic Disorders
  • Gastroenterology

Background:

  • Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum from simple fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH), characterized by inflammation and liver cell injury.
  • NAFLD is associated with significant risks including progressive fibrosis, cirrhosis, hepatocellular carcinoma, and cardiovascular complications.
  • High prevalence worldwide, affecting 10-40% of adults and being the most common liver disease in children, underscores its public health importance.

Purpose of the Study:

  • To review the current understanding of NAFLD pathophysiology, including fat accumulation, inflammation, fibrosis, and the role of gut microbiota.
  • To discuss the genetic and epigenetic factors contributing to disease variability.
  • To highlight the limitations of current diagnostic methods and the ongoing development of non-invasive strategies.

Main Methods:

  • Review of existing literature on NAFLD pathogenesis, clinical presentation, and diagnostic approaches.
  • Analysis of emerging research on mechanistic insights and potential therapeutic targets.
  • Evaluation of diagnostic tools, including imaging and non-invasive biomarkers, in comparison to liver biopsy.

Main Results:

  • NAFLD is strongly linked to insulin resistance, obesity, and metabolic syndrome.
  • Mechanisms involving fat accumulation, hepatocyte injury, immune response, fibrosis, and gut microbiota are critical to NAFLD progression.
  • Genetic and epigenetic factors influence individual disease phenotypes and progression rates.

Conclusions:

  • Effective medical interventions for NAFLD reversal are limited, with lifestyle modifications and bariatric surgery being primary options.
  • Investigational strategies aim to target key pathophysiological pathways like fatty acid overload, cell injury, and inflammation.
  • Non-invasive diagnostic methods are being developed to complement or replace liver biopsy for improved patient monitoring.